Suppr超能文献

母亲在怀孕期间使用大麻与母婴不良结局。

Maternal Cannabis Use During Pregnancy and Maternal and Neonatal Adverse Outcomes.

机构信息

Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India; Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India (

出版信息

J Clin Psychiatry. 2024 Oct 30;85(4):24f15611. doi: 10.4088/JCP.24f15611.

Abstract

Cannabis is a psychoactive substance the availability and use of which, in various forms, has been liberalized in many countries across the world. Cannabis use, including by women of reproductive age, has become increasingly common, with (in some studies) >5% of women using the substance even during pregnancy to self treat nausea, vomiting, stress, anxiety, depression, insomnia, chronic pain, and other conditions. Women who use cannabis during pregnancy are more likely to have a medical or mental health condition; they are commonly unaware that cannabis is associated with pregnancy related risks. These risks arise from effects of cannabis on cannabinoid receptors in the placenta as well as from cannabis constituents that cross the placenta and act on receptors in the developing fetal brain; other mechanisms may also operate. This article examines recent cohort studies and meta-analyses on specific maternal and neonatal adverse outcomes associated with gestational exposure to cannabis. Maternal cannabis use during pregnancy is associated with small to moderately increased risks of gestational hypertension, gestational weight gain less than as well as greater than guidelines, and placental abruption. Maternal cannabis use during pregnancy is also associated with small to moderately increased risks of preterm birth (<36 weeks, <34 weeks, and <32 weeks), small for gestational age, low birth weight, neonatal intensive care unit admission, and fetal death. The risk of some of these adverse outcomes is greater with greater frequency of cannabis use. These adverse outcomes have been identified even in women who do not use other substances during pregnancy. Other adverse outcomes, such as major congenital malformations and neurodevelopmental disorders, are also reported (but are not discussed in this article). For these and other reasons, many professional bodies across the world are already discouraging women from using cannabis during pregnancy. It is important for pregnant women to be educated about cannabis and pregnancy related risks in a shared decision-making process.

摘要

大麻是一种精神活性物质,在世界上许多国家,其各种形式的供应和使用已经放宽。大麻的使用,包括育龄妇女在内,变得越来越普遍,(在一些研究中)甚至有 5%以上的妇女在怀孕期间使用这种物质来自我治疗恶心、呕吐、压力、焦虑、抑郁、失眠、慢性疼痛和其他疾病。在怀孕期间使用大麻的妇女更有可能患有医疗或精神健康状况;她们通常不知道大麻与与怀孕相关的风险有关。这些风险源于大麻对胎盘内大麻素受体的影响,以及大麻成分穿过胎盘并作用于发育中胎儿大脑内受体的影响;其他机制也可能起作用。本文研究了最近关于与妊娠期间接触大麻相关的特定产妇和新生儿不良结局的队列研究和荟萃分析。母亲在怀孕期间使用大麻与妊娠高血压、妊娠体重增加低于和高于指南、胎盘早剥的风险增加相关。母亲在怀孕期间使用大麻也与早产(<36 周、<34 周和<32 周)、小于胎龄儿、低出生体重、新生儿重症监护病房入院和胎儿死亡的风险增加相关。使用大麻的频率越高,这些不良结局的风险就越大。即使在怀孕期间不使用其他物质的女性中,也已经发现了这些不良结局。其他不良结局,如重大先天性畸形和神经发育障碍,也有报道(但本文未讨论)。出于这些和其他原因,世界上许多专业机构已经不鼓励妇女在怀孕期间使用大麻。在共同决策过程中,向孕妇提供关于大麻和与怀孕相关的风险的教育非常重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验